IQVIA HOLDINGS INC (QTS.DE) Stock Fundamental Analysis
Europe - FRA:QTS - US46266C1053 - Common Stock
175.35 EUR
+13.25 (+8.17%)
Overall QTS gets a fundamental rating of 4 out of 10. We evaluated QTS against 20 industry peers in the Life Sciences Tools & Services industry. While QTS has a great profitability rating, there are quite some concerns on its financial health. QTS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year QTS was profitable.
In the past year QTS had a positive cash flow from operations.
Each year in the past 5 years QTS has been profitable.
In the past 5 years QTS always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.32%, QTS is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
QTS has a Return On Equity of 21.41%. This is amongst the best in the industry. QTS outperforms 94.44% of its industry peers.
QTS has a better Return On Invested Capital (9.40%) than 72.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QTS is in line with the industry average of 7.27%.
The 3 year average ROIC (8.99%) for QTS is below the current ROIC(9.40%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.32% | ||
| ROE | 21.41% | ||
| ROIC | 9.4% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
1.3 Margins
QTS has a Profit Margin of 7.88%. This is in the better half of the industry: QTS outperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of QTS has grown nicely.
QTS has a Operating Margin of 14.41%. This is comparable to the rest of the industry: QTS outperforms 44.44% of its industry peers.
In the last couple of years the Operating Margin of QTS has grown nicely.
QTS has a Gross Margin of 34.25%. This is comparable to the rest of the industry: QTS outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of QTS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | 7.88% | ||
| GM | 34.25% |
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QTS is destroying value.
The number of shares outstanding for QTS has been reduced compared to 1 year ago.
Compared to 5 years ago, QTS has less shares outstanding
Compared to 1 year ago, QTS has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.00 indicates that QTS is not a great score, but indicates only limited risk for bankruptcy at the moment.
QTS's Altman-Z score of 2.00 is on the low side compared to the rest of the industry. QTS is outperformed by 66.67% of its industry peers.
QTS has a debt to FCF ratio of 7.71. This is a slightly negative value and a sign of low solvency as QTS would need 7.71 years to pay back of all of its debts.
QTS has a Debt to FCF ratio of 7.71. This is in the lower half of the industry: QTS underperforms 61.11% of its industry peers.
QTS has a Debt/Equity ratio of 2.45. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.45, QTS is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.45 | ||
| Debt/FCF | 7.71 | ||
| Altman-Z | 2 |
ROIC/WACC0.93
WACC10.14%
2.3 Liquidity
QTS has a Current Ratio of 0.84. This is a bad value and indicates that QTS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of QTS (0.84) is worse than 88.89% of its industry peers.
QTS has a Quick Ratio of 0.84. This is a bad value and indicates that QTS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.84, QTS is doing worse than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
QTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.13%, which is quite good.
The Earnings Per Share has been growing by 11.72% on average over the past years. This is quite good.
The Revenue has been growing slightly by 3.60% in the past year.
Measured over the past years, QTS shows a small growth in Revenue. The Revenue has been growing by 6.80% on average per year.
EPS 1Y (TTM)9.13%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%6.44%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.32%
3.2 Future
Based on estimates for the next years, QTS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.04% on average per year.
QTS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.48% yearly.
EPS Next Y7.56%
EPS Next 2Y8.11%
EPS Next 3Y8.74%
EPS Next 5Y10.04%
Revenue Next Year5.12%
Revenue Next 2Y5.04%
Revenue Next 3Y5.27%
Revenue Next 5Y5.48%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.93, which indicates a rather expensive current valuation of QTS.
QTS's Price/Earnings ratio is a bit cheaper when compared to the industry. QTS is cheaper than 77.78% of the companies in the same industry.
QTS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
QTS is valuated correctly with a Price/Forward Earnings ratio of 15.80.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QTS indicates a somewhat cheap valuation: QTS is cheaper than 77.78% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.32. QTS is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.93 | ||
| Fwd PE | 15.8 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QTS is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, QTS is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.4 | ||
| EV/EBITDA | 14.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QTS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.37
PEG (5Y)1.53
EPS Next 2Y8.11%
EPS Next 3Y8.74%
5. Dividend
5.1 Amount
QTS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:QTS (10/3/2025, 7:00:00 PM)
175.35
+13.25 (+8.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.98%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner ChangeN/A
Market Cap29.81B
Analysts81.38
Price Target187.84 (7.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1%
Min EPS beat(2)0.45%
Max EPS beat(2)1.56%
EPS beat(4)3
Avg EPS beat(4)0.36%
Min EPS beat(4)-0.62%
Max EPS beat(4)1.56%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)9
Avg EPS beat(12)0.84%
EPS beat(16)13
Avg EPS beat(16)1.1%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.4%
Max Revenue beat(2)0.5%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-0.14%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)7
Avg Revenue beat(16)-0.12%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.93 | ||
| Fwd PE | 15.8 | ||
| P/S | 2.23 | ||
| P/FCF | 17.4 | ||
| P/OCF | 13.37 | ||
| P/B | 6.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.22 |
EPS(TTM)9.78
EY5.58%
EPS(NY)11.1
Fwd EY6.33%
FCF(TTM)10.08
FCFY5.75%
OCF(TTM)13.12
OCFY7.48%
SpS78.71
BVpS28.97
TBVpS-72.33
PEG (NY)2.37
PEG (5Y)1.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.32% | ||
| ROE | 21.41% | ||
| ROCE | 10.75% | ||
| ROIC | 9.4% | ||
| ROICexc | 10.5% | ||
| ROICexgc | N/A | ||
| OM | 14.41% | ||
| PM (TTM) | 7.88% | ||
| GM | 34.25% | ||
| FCFM | 12.8% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
ROICexc(3y)9.76%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.28%
ROCE(5y)8.4%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y16.83%
ROICexc growth 5Y22.05%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
F-Score4
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.45 | ||
| Debt/FCF | 7.71 | ||
| Debt/EBITDA | 4.19 | ||
| Cap/Depr | 54.1% | ||
| Cap/Sales | 3.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 77.31% | ||
| Profit Quality | 162.49% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 2 |
F-Score4
WACC10.14%
ROIC/WACC0.93
Cap/Depr(3y)57.12%
Cap/Depr(5y)53.97%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.59%
Profit Quality(3y)136.6%
Profit Quality(5y)225.89%
High Growth Momentum
Growth
EPS 1Y (TTM)9.13%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%6.44%
EPS Next Y7.56%
EPS Next 2Y8.11%
EPS Next 3Y8.74%
EPS Next 5Y10.04%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.32%
Revenue Next Year5.12%
Revenue Next 2Y5.04%
Revenue Next 3Y5.27%
Revenue Next 5Y5.48%
EBIT growth 1Y7.86%
EBIT growth 3Y17.1%
EBIT growth 5Y21.64%
EBIT Next Year21.15%
EBIT Next 3Y11.05%
EBIT Next 5Y9.31%
FCF growth 1Y27.05%
FCF growth 3Y-2.8%
FCF growth 5Y20.42%
OCF growth 1Y16.73%
OCF growth 3Y-2.63%
OCF growth 5Y13.9%